Phase of Development: Lead Optimization
Mechanism of Action: Tau Phosphorylation and Posttranslational Modifications
Compound Type/Modality: Antibody/Biologic
Developing Biomarkers and Vectorized Immunotherapy Targeting Acetylated Tau
Li Gan, PhD
Director, Helen and Robert Appel Alzheimer's Disease Research Institute
Cornell Weill Medical Institute (New York, NY)